Engineered nanoparticles sensitize gliomas to radiotherapy

Дата публикации: 21-09-2026 20:20:01

Gliomas are a major cause of cancer-related deaths in younger adults. About 7,000 patients harbor a common genetic mutation that affects the enzyme isocitrate dehydrogenase 1. This mutated enzyme, called mIDH1, can produce a molecule that can reprogram both the tumor cells and the environment in which they grow. The molecule, known as 2-hydroxyglutarate, can also circulate in the blood and reprogram immune cells in the bone marrow.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma	0	15.89	10-09-2026
2	New AI tool can predict where glioblastoma is most likely to return after initial surgery	0	5.59	28-09-2026
3	Targeted nanoparticles reduce tumor scarring and enable immunotherapy response in mice	0	7.8	25-09-2026
4	Ученые создали вакцину против опухолей мозга	0	11.7	12-07-2026
5	Gold nanoplasmonic chip tracks L-DOPA response in Parkinson's 'mini-brains'	0	15.51	22-09-2026
6	Опухоль может строить собственное "гнездо" внутри мозга, выяснили ученые	0	7.9	28-09-2026
7	Онколог Каприн рассказал о сложностях лечения глиобластомы	0	8.34	04-10-2026
8	New nanoparticle drug-delivery method may improve treatment for endometriosis	0	9.82	21-09-2026
9	Injectable nanoparticles make blind retinas respond to light in preclinical study	0	4.68	22-09-2026
10	Alzheimer's hope: Nanoparticles regenerate cells to restore memory	0	11.49	31-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.54. Источник: phys.org.